American International Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

American International Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28,177	Closed	-$1.69M	–	3088
2019 Q4	$1.69M	Sell	28,177 -237	-0.8%	-$8.89K	0.01%	1071
2019 Q3	$798K	Buy	28,414 +527	+2%	+$18K	﹤0.01%	1412
2019 Q2	$1.06M	Buy	27,887 +4,165	+18%	+$160K	﹤0.01%	1288
2019 Q1	$926K	Sell	23,722 -767	-3%	-$22K	﹤0.01%	1362
2018 Q4	$522K	Buy	24,489 +2,909	+13%	+$75.1K	﹤0.01%	1652
2018 Q3	$854K	Buy	21,580 +722	+3%	+$26.9K	﹤0.01%	1541
2018 Q2	$797K	Buy	20,858 +8,029	+63%	+$297K	﹤0.01%	1533
2018 Q1	$386K	Buy	12,829 +1,761	+16%	+$59.6K	﹤0.01%	1890
2017 Q4	$346K	Buy	11,068 +837	+8%	+$23K	﹤0.01%	2000
2017 Q3	$287K	Buy	10,231 +765	+8%	+$16.6K	﹤0.01%	2077
2017 Q2	$181K	Buy	9,466 +6,081	+180%	+$97.1K	﹤0.01%	2333
2017 Q1	$58K	Buy	+3,385	New	+$54.8K	﹤0.01%	2802

American International Group's BOLD Position: Q1 2020 in Review

American International Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 28,177 shares — an estimated $1.69M sold.

American International Group first reported a position in BOLD in Q1 2017 and held it in 12 quarters. The position peaked at $1.69M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

American International Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
American International Group sold 28,177 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.69M.
American International Group first reported a position in Audentes Therapeutics, Inc in Q1 2017 and held it in 12 quarters.
American International Group's Audentes Therapeutics, Inc position peaked at $1.69M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on American International Group's 13F filing for Q1 2020, filed 4 May 2020.